Sept 6, 2012
Vitae Pharmaceuticals to present the poster, "VTP-4, a Potent and Selective LXRß Modulator for Potential Treatment of Atherosclerosis" at the Frontiers in Lipid Biology Meeting in Banff, AB.
July 18, 2012
Vitae Pharmaceuticals to present the poster, " A Novel LXRbeta-selective Partial Agonist Increases the ApoE-ABCA1 Pathway and Decreases Hippocampal Abeta in Cynomolgus Monkeys without Increasing Liver Triglycerides," at the 2012 Alzheimer's Association International Conference (AAIC) in Vancouver, BC.
October 28, 2008
Vitae Pharmaceuticals Secures $13 Million In Debt Financing